Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer

NAOHIRO FUJIMOTO; YUTO TSUBONUMA; YUJIRO NAGATA; AKINORI MINATO; IKKO TOMISAKI; KENICHI HARADA; HIROSHI MIYAMOTO

doi:10.21873/anticanres.16571

Article Information

vol. 43 no. 9 3841-3847

DOI

https://doi.org/10.21873/anticanres.16571

PubMed

37648316

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received June 8, 2023
Revision received July 5, 2023
Accepted July 17, 2023
Published online August 30, 2023.

Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

NAOHIRO FUJIMOTO¹ ⇑,
YUTO TSUBONUMA¹,
YUJIRO NAGATA¹,
AKINORI MINATO¹,
IKKO TOMISAKI¹,
KENICHI HARADA¹ and
HIROSHI MIYAMOTO²

¹Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan;
²Department of Pathology & Laboratory of Medicine and Urology, University of Rochester Medical Center, Rochester, NY, U.S.A.

Correspondence to: Naohiro Fujimoto MD, Ph.D., Department of Urology, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan. Tel: +81 936917446, Fax: +81 936038724, e-mail: n-fuji{at}med.uoeh-u.ac.jp

View Full Text